Roche Virtual Event – Update following ASH 2022
Agenda
Welcome
Hematology franchise overview
Review of key clinical data presented at ASH
Spark Therapeutics, Inc. (SPK-8011) clinical data update
Bruno Eschli, Head of Investor Relations
Peter Ahnesorg, Franchise Head Hematology
Charles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development
Gallia G. Levy, MD, PhD, Chief Medical and Product Strategy Officer

Please register to access the replay*

*Privacy notice

Investors
Past IR Events
View more Events

Roche has hosted a virtual event on Wednesday, 14 December 2022.

Downloads

Discover more